We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NewLink Genetics Corporation | NASDAQ:NLNK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.89 | 0.85 | 0.915 | 0 | 01:00:00 |
Delaware
|
001-35342
|
42-1491350
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
2503 South Loop Drive
Ames, IA
|
50010
|
(Address of principal executive offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☒ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
NLNK
|
The Nasdaq Stock Market
|
(d) |
Exhibits
|
Exhibit
Number
|
Description
|
|
Press Release, dated December 20, 2019, entitled “NewLink Genetics Announces FDA Approval of Ebola Vaccine V920 (ERVEBO®).”
|
||
NEWLINK GENETICS CORPORATION
|
||
Dated: December 20, 2019
|
By:
|
/s/ Brad J. Powers
|
Name: Brad J. Powers
|
||
Title: General Counsel
(Principal Executive Officer)
|
1 Year NewLink Genetics Chart |
1 Month NewLink Genetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions